http://www.xconomy.com/detroit/2011/12/09/nanobio-merck-to-collaborate-on-gates-funded-rsv-vaccine/
Rob Lambkin-Williams BSc, PhD, MRPharmS
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment